Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers (Virtual Conference) Spring 2024

May 16, 2024 to May 18, 2024

- This conference will be a virtual (online) event. -

The demand for cancer care is expected to grow 40% over the next six years and ASCO is projecting a shortage of more than 2,200 oncologists by 2025. To meet the cancer care needs of patients, advanced practice providers (APPs), whose education and training is focused on health promotion, disease prevention, and primary care medical management, have increasingly been sought to fill the shortage. However, many APPs have little background or training in oncology. As a result, oncology practices need to provide new staff with an onboarding program that helps to establish a working baseline level of knowledge of hematology and oncology.

To help APPs prepare for a new career in the specialty of oncology, Horizon CME in partnership with APAO has developed “Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers”. In this two-and-a-half-day program, clinicians will gain a basic understanding of cancer therapies, benign and malignant hematologic disorders, solid malignancies, supportive care strategies, oncologic emergencies, genetics and molecular testing, and more. Participation in this program will provide APPs with the foundational knowledge they need to provide support and care to cancer patients as part of the multidisciplinary oncology care team.

This program is appropriate for new APPs, nurses, and pharmacists in oncology, clinicians seeking a review, or clinicians considering a career in oncology.

 Registration 

 Pricing

 Deadline

 Early Bird

 $100

 February 16, 2024

 Advanced 

 $125

 April 16, 2024

 General Registration

 $150

 May 16, 2024

 Student/Fellows*

 $25

 

 Industry Employee** registration is date based pricing +$300

*Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession.

If you would like to attend as a Student, please contact info@horizoncme.com for further information.

**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc). 

Learning Objectives.

  • Describe the presentation, evaluation, and treatment of common, solid, and hematologic malignancies
  • Recognize the presentation, evaluation, and treatment of common benign hematologic disorders
  • Summarize the role of genetics and molecular testing in cancer care
  • Compare and contrast the various types of cancer treatment including stem cell transplant, chemotherapy, targeted therapies, radiotherapy, and immunotherapy
  • Identify and appropriately manage common oncologic emergencies
  • Outline the role of palliative care and effectively incorporate it into oncology practice

Target Audience

This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.

Presented By                                                  In Partnership with

                                                                  

Course summary
Available credit: 
  • 17.25 AMA PRA Category 1 Credit
    Horizon CME designates this Live activity for a maximum of 17.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 17.25 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 17.25 credit.
  • 3.25 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 3.25 credit.
Course opens: 
11/30/2023
Course expires: 
06/20/2024
Event starts: 
05/16/2024 - 10:00am PDT
Event ends: 
05/18/2024 - 12:00pm PDT
Cost:
$150.00
Rating: 
0

Please note: times are subject to change. Please check the syllabus for the most current version of the program.

Commercial Support: This activity is supported in part by an independent medical education grant from Merck Sharp & Dohme LLC and Regeneron Pharmaceuticals, Inc.

All Times Listed are for the Eastern Standard Time Zone

Thursday, May 16, 2024

1:00pm Welcome, Introductions, & CE Housekeeping
1:10pm (01) How to Build an APP Practice While Maximizing Productivity
» Heather Koniarczyk, MSN, APRN-CNP, AOCNP - Cleveland Clinic - Taussig Cancer Institute
1:40pm Stump the Faculty - Panel Q&A Discussion
1:55pm(02) Immunotherpies
» Marianne Davies, DNP, ACNP, AOCNP, FAAN - Yale Comprehensive Cancer Center
2:55pm (03) Pain Management in Cancer Care
» Matthew Robinson, DO, MS - University of Tennessee Health Science Center Administration and Services
3:40pm Stump the Faculty - Panel Q&A Discussion
3:55pm Meet-the-Clinician Break
4:25pm (04) Precision Medicine: The Role of Biomarker Testing in Cancer
» Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN - Cleveland Clinic
» Beth Sandy, MSN, CRNP - Abramson Cancer Center, University of Pennsylvania
5:10pm Stump the Faculty - Panel Q&A Discussion
5:25pm Adjourn

Friday, May 17, 2024

7:50am Welcome, Introductions, & CE Housekeeping
8:00am (05) Introduction to Malignant Hematology
» Jennie M. Goble, DMSc, PA-C - Mayo Clinic
» Lisa Nodzon, PhD, APRN, AOCNP - Moffitt Cancer Center
» Marie (Rosie) Guerrero, DNP, NP-C, AOCNP - The University of Texas, MD Anderson Cancer Center
» Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN - Cleveland Clinic
9:45am Stump the Faculty-Panel Q&A Discussion
10:00am Meet-the-Clinician Break
10:25am (06) Chemotherapy Review
» Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP - University of Illinois College of Pharmacy
11:25am Stump the Faculty - Panel Q&A Discussion
11:40am Meet-the-Clinician Break
12:40pm (07) Introduction to Benign Hematology
» Peter Hakos, PA-C - Clevelan Clinic
» Lauren Imboden, PA-C - Atrium Health Wake Forest Baptist
2:10pm (08) Introduction to Allogeneic Stem Cell Transplantation
» Christina Ferraro, CNP - Cleveland Clinic
2:40pm Stump the Faculty - Panel Q&A Discussion
2:55pm Meet-the-Clinician Break
3:20pm (09) CAR-T Cell Therapy
» Patricia Mangan, RN, MSN, CRNP - University of Pennsylvania
3:50pm (10) The Basics of BiSpecifics
» Ellen Marin, PA-C - Winship Cancer Institute at Emory University
4:20pm (11) Difficult Conversations and End of Life Care
» Justin Baker, MD - Stanford School of Medicine
5:05pm Stump the Faculty - Panel Q&A Discussion
5:20pm Adjourn

Saturday, May 18, 2024

7:50am Welcome & Introductions
8:00am (12) Introduction to Solid Malignancies - Part 1
» Jamie Carroll, APRN, CNP, MSN - Mayo Clinic
» Beth Sandy, MSN, CRNP - Abramson Cancer Center, University of Pennsylvania 
» Kathleen Boyle, DScPAS, PAC - Dana-Farber Cancer Institute
» Jessica Walchonski, PA-C - UCLA Health
» Grace Baek, PharmD, BCOP - Fred Hutchinson Cancer Center
10:00am Stump the Faculty - Panel Q&A Discussion
10:15am Meet-the-Clinician Break
10:40am (13) Targeted Therapies
» Jennifer Murphy, PharmD, BCOP - UCD Health, Oncology, and Investigational Drug Service
11:25am (14) Oncologic Emergencies
» Meredith Beaton, MSN, RN, AG-ACNP - UCHealth Anschutz
11:55am Stump the Faculty – Panel Q&A Discussion
12:10pm Meet-the-Clinician Break
12:45pm (15) Cancer Survivorship
» Todd Hultman, PhD, ACNP, ACHPN - Presbyterian Healthcare Services
1:30pm (16) Introduction to Solid Malignancies – Part 2
» Laura S. Wood, RN, MSN, OCN - Cleveland Clinic
» Michael Lai, ARNP - Fred Hutchinson Cancer Center
2:15pm (17) Supportive Care
» Laura J. Zitella, MS, RN, ACNP-BC, AOCN - Hematology/Oncology Nurse Practitioner 
3:15pm Stump the Faculty – Panel Q&A Discussion
3:30pm Closing Remarks
Online - Virtual Event
United States

This program is in EST Eastern Standard Time.

Available Credit

  • 17.25 AMA PRA Category 1 Credit
    Horizon CME designates this Live activity for a maximum of 17.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 17.25 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 17.25 credit.
  • 3.25 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 3.25 credit.

Price

Cost:
$150.00
Please login or register to take this course.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above


Supported Phones & Tablets:

Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above

How to obtain credit for attendance (eligibility requirement and process for obtaining certificate)
To receive documentation of credit, participants must:

  1. Login to the educational portal

  2. Attend the educational activity

  3. Complete the post test and online evaluation form. 

  4. Attest to the number of hours in attendance in order to generate your certificate 

*Requests from learners to claim credit after the evaluation closes will not be granted